Literature DB >> 21173373

Predicting the prognosis of oral squamous cell carcinoma after first recurrence.

Michael D Kernohan1, Jonathan R Clark, Kan Gao, Ardalan Ebrahimi, Christopher G Milross.   

Abstract

OBJECTIVES: to describe the clinicopathologic features of oral squamous cell carcinoma in patients who develop locoregional recurrence of disease, to identify factors that predict prognosis in the subset of patients treated with salvage surgery, and to determine the adjusted effect of time to recurrence.
DESIGN: cohort study.
SETTING: a head and neck cancer institute in Sydney, New South Wales, Australia. PATIENTS: a total of 77 patients who underwent salvage surgery for oral squamous cell carcinoma that had been treated initially by surgery, radiotherapy, or surgery with postoperative radiotherapy. MAIN OUTCOME MEASURES: univariable and multivariable analysis of clinical and pathologic risk factors.
RESULTS: median time to recurrence from initial treatment was 7.5 months (range, 0.9-143.9 mo), with 86% of recurrences occurring within the first 24 months. Surgical salvage was attempted in 77 patients who had experienced recurrence at the primary site (n = 39), ipsilateral neck (n = 27), and contralateral neck (n = 11). Time to recurrence, initial treatment modality, and site of failure were independent prognostic variables.
CONCLUSIONS: the relationship of these prognostic variables displays a dynamic interaction. Initial combined-modality treatment and shorter time to recurrence were associated with worse outcome, while the effect of site of recurrence (local vs regional) was dependent on an interaction with the time to recurrence. The result of this interaction was that local recurrence was worse for those who experienced it early (eg, <6 mo after the initial treatment) and nodal recurrence was worse for those who experienced it late (eg, ≥ 6 mo after the intial treatment).

Entities:  

Mesh:

Year:  2010        PMID: 21173373     DOI: 10.1001/archoto.2010.214

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  15 in total

1.  Estimating Survival After Salvage Surgery for Recurrent Oral Cavity Cancer.

Authors:  Samantha Tam; Rakhna Araslanova; Tsu-Hui Hubert Low; Andrew Warner; John Yoo; Kevin Fung; S Danielle MacNeil; David A Palma; Anthony C Nichols
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-07-01       Impact factor: 6.223

2.  Predictors of locoregional recurrence in T1-2N0 tongue cancer patients.

Authors:  Souichi Yanamoto; Shin-ichi Yamada; Hidenori Takahashi; Goro Kawasaki; Hisazumi Ikeda; Takeshi Shiraishi; Shuichi Fujita; Tohru Ikeda; Izumi Asahina; Masahiro Umeda
Journal:  Pathol Oncol Res       Date:  2013-05-17       Impact factor: 3.201

3.  Intraoperative frozen section histological analysis of resection samples is useful for the control of primary lesions in patients with oral squamous cell carcinoma.

Authors:  Akihiko Miyawaki; Hiroshi Hijioka; Takayuki Ishida; Etsuro Nozoe; Norifumi Nakamura; Ryoichi Oya
Journal:  Mol Clin Oncol       Date:  2014-09-04

4.  Choice of Regional Flaps for Oral Cancer Defects: Relevance in Current Era.

Authors:  G Lakshminarayana; Shruti Venkitachalam; C S Mani
Journal:  J Maxillofac Oral Surg       Date:  2019-11-22

5.  Cisplatin-Resistance in Oral Squamous Cell Carcinoma: Regulation by Tumor Cell-Derived Extracellular Vesicles.

Authors:  Xin-Hui Khoo; Ian C Paterson; Bey-Hing Goh; Wai-Leng Lee
Journal:  Cancers (Basel)       Date:  2019-08-14       Impact factor: 6.639

6.  The Highly Pure Neem Leaf Extract, SCNE, Inhibits Tumorigenesis in Oral Squamous Cell Carcinoma via Disruption of Pro-tumor Inflammatory Cytokines and Cell Signaling.

Authors:  Jay Morris; Cara B Gonzales; Jorge J De La Chapa; April B Cabang; Christos Fountzilas; Mandakini Patel; Stephanie Orozco; Michael J Wargovich
Journal:  Front Oncol       Date:  2019-09-13       Impact factor: 6.244

7.  Time patterns of recurrence and second primary tumors in a large cohort of patients treated for oral cavity cancer.

Authors:  Maria T Brands; Elisabeth A J Smeekens; Robert P Takes; Johannes H A M Kaanders; Andre L M Verbeek; Matthias A W Merkx; Sandra M E Geurts
Journal:  Cancer Med       Date:  2019-08-10       Impact factor: 4.452

8.  Aberrant Expression Of PDCD4/eIF4A1 Signal Predicts Postoperative Recurrence For Early-Stage Oral Squamous Cell Carcinoma.

Authors:  Mengxiang Zhao; Liang Ding; Yan Yang; Sheng Chen; Nisha Zhu; Yong Fu; Yanhong Ni; Zhiyong Wang
Journal:  Cancer Manag Res       Date:  2019-11-11       Impact factor: 3.989

9.  Clinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinoma.

Authors:  Toshima Z Parris; Luaay Aziz; Anikó Kovács; Shahin Hajizadeh; Szilárd Nemes; May Semaan; Chang Yan Chen; Per Karlsson; Khalil Helou
Journal:  BMC Cancer       Date:  2014-05-07       Impact factor: 4.430

10.  Early oral tongue cancer initially managed with surgery alone: Treatment of recurrence.

Authors:  Jeffrey C Liu; Dennis S Sopka; Ranee Mehra; Miriam N Lango; Christopher Fundakowski; John A Ridge; Thomas J Galloway
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2016-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.